PriscillaYingHsueMD

Cardiology • Los Angeles, CA

Adult Congenital Heart Disease

Associate Professor, Medicine, University of California, San Francisco, School of Medicine

Join to view full profile

Dr. Hsue is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hsue's full profile

Already have an account?

Office
100 Medical Plaza Driveway Suite 630
Los Angeles, CA 90095
Phone+1 310-825-9011

Fax+1 415-206-3872

Education & Training

University of California (San Francisco)Fellowship, Cardiovascular Disease, 1999 - 2002
University of California (San Francisco)Residency, Internal Medicine, 1996 - 1999
University of California San Francisco School of MedicineClass of 1996

Certifications & Licensure

CA State Medical License 1998 - 2026
American Board of Internal Medicine Cardiovascular Disease

Clinical Trials

Effect of Raltegravir on Endothelial Function in HIV-Infected Patients Start of enrollment: 2009 Jan 01
Completed
Phase 4
Effect of Maraviroc on Endothelial Function in HIV-Infected Patients Start of enrollment: 2010 Jan 01
Completed
Phase 3
Atherosclerosis in Rheumatoid Arthritis Start of enrollment: 2009 Sep 01
Completed
The Role of Inflammation and Aging in HIV-Associated Cardiovascular Risk Start of enrollment: 2010 Apr 01
Completed
Investigation of The Effect of Cenicriviroc (CVC) Plus FTC/TDF on Cardiovascular Disease Risk Factors Start of enrollment: 2011 Sep 01
Terminated
Inflammation, Viral Replication, and Atherosclerosis in Treated HIV Infection Start of enrollment: 2003 Jul 01
Completed
Study of Adalimumab to Lower Cardiovascular Risk in RA Patients With Well Controlled Joint Disease Start of enrollment: 2013 Jul 01
Completed
Phase 4
Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications Start of enrollment: 2014 Jan 31
Completed
Phase 2
Effects of COVID-19 Convalescent Plasma (CCP) on Coronavirus-associated Complications in Hospitalized Patients Start of enrollment: 2020 Jun 09
Completed
Phase 2
Immunomodulation Using VB-201 to Reduce Arterial Inflammation in Treated HIV - VITAL HIV Trial Start of enrollment: 2022 Jul 01
Withdrawn
Phase 1, Phase 2
Roles: Contact, Sponsor-Investigator, Principal Investigator
REVERSE-Long COVID-19 With Baricitinib Study Start of enrollment: 2024 Jun 15
Not yet recruiting
Phase 3
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

HIV-Associated Heart Failure: Phenotypes and Clinical Outcomes in a Safety-Net Setting.
Matthew S Durstenfeld, Anjali Thakkar, Diane Jeon, Robert Short, Yifei Ma
Journal of the American Heart Association. 2024-12-03
Ambulatory Rhythm Monitoring in People Living With HIV: A Cross-Sectional Analysis From a Comparative Cohort.
Cody Cichowitz, Godfrey A Kisigo, Salama P Fadhil, Grace Ruselu, Nikola Fajkis-Zajączkowska
JACC. Clinical Electrophysiology. 2024-11-01
Stakeholder Perspectives on a Heart Failure With Reduced Ejection Fraction Polypill: A Multi-Center Mixed Methods Study.
Justin C Chen, Colette DeJong, Mansi Agarwal, Amaris M Hairston, Matthew S Durstenfeld
Circulation. Cardiovascular Quality and Outcomes. 2024-11-01

Journal Articles

Association of Viral Persistence and Atherosclerosis in Adults with Treated HIV Infection
Jeffrey N Martin, Steven G Deeks, Priscilla Y Hsue, JAMA Network Open
Inflammation, Immunity, and Infection in Atherothrombosis
Paul M Ridker, Valentin Fuster, Priscilla Y Hsue, Peter Libby, ScienceDirect
Safety and Impact of Low-Dose Methotrexate on Endothelial Function and Inflammation in Individuals with Treated Human Immunodeficiency Virus: AIDS Clinical Trials Grou...
Steven G Deeks, James H Stein, Carl Fichtenbaum, Judith S Currier, Priscilla Y Hsue, Eric S Daar, Ahmed Tawakol, Michael Lederman, Tanvir Bell, Diane Havlir, Clinical Infectious Diseases

Press Mentions

Chinese American Immigrants Face Higher Risk of Cardiovascular Disease Depending on Length of Residence and Location in the U.S.September 5th, 2024
How Prolonged COVID-19 Influences Physical PerformanceOctober 21st, 2022
UCSF: New Study Shows Long COVID May Impact Exercise AbilityOctober 12th, 2022
Join now to see all

Grant Support

Inflammation, Viral Replication, And Atherosclerosis In Treated HIV InfectionNational Heart, Lung, And Blood Institute2008–2011
Epidemiology And Pathogenesis Of Pulmonary Hypertension In HIV PatientsNational Heart, Lung, And Blood Institute2007–2011
Pathogenesis Of Atherosclerosis In HIV Patients On HaartNational Institute Of Allergy And Infectious Diseases2005–2009
Immunologic And Inflammatory Factors In Patients With HIVNational Center For Research Resources2005
HHV-8 And Pulmonary Arterial Pressures In Patients With HIV InfectionNational Center For Research Resources2005